BioMarin Pharmaceutical (BMRN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$66.53+0.15%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BMRN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 3,406.6 | 3,221.3 | 2,853.9 | 2,419.2 | 2,096.0 | 1,846.3 | 1,860.5 | 1,704.0 | 1,491.2 | 1,313.6 | 1,116.9 | 889.9 | 749.3 | 548.5 | 500.7 | 441.4 | 376.3 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,313.6 | 1,116.9 | 889.9 | 749.3 | 548.5 | 500.7 | 441.4 | 376.3 |
| Cost of Revenues | 813.6 | 717.4 | 580.2 | 532.1 | 503.0 | 470.5 | 524.3 | 359.5 | 315.3 | 241.8 | 209.6 | 152.0 | 122.3 | 88.4 | 91.8 | 84.0 | 70.3 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 1,368.5 | 1,153.0 | 1,009.0 | 892.4 | 823.2 | 759.4 | 737.7 | 680.9 | 604.4 | 554.3 | 476.6 | 402.3 | 302.2 | 235.4 | 198.2 | 175.4 | 151.7 |
| R&D Expenses | 987.6 | 921.9 | 747.2 | 746.8 | 649.6 | 628.8 | 628.1 | 715.0 | 696.3 | 610.8 | 661.9 | 634.8 | 461.5 | 354.8 | 302.2 | 214.4 | 147.3 |
| Other Operating Expenses, Total | 13.4 | 9.0 | (4.7) | (38.2) | (13.5) | 11.8 | 7.1 | 6.4 | 2.2 | 8.0 | 4.9 | (9.5) | (0.4) | 1.0 | (1.8) | — | — |
| Operating Income | 149.3 | 409.5 | 484.2 | 185.8 | 161.0 | (82.3) | (43.4) | (100.5) | (123.5) | (14.7) | (803.4) | (110.7) | (92.9) | (156.0) | (110.2) | (33.9) | 0.5 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 10.9 | 12.7 | 17.3 | 16.0 | 15.3 | 29.3 | 23.5 | 43.7 | 42.7 | 39.5 | 38.2 | 36.6 | 10.4 | 7.6 | 8.4 | 10.8 |
| Interest & Investment Income | 70.1 | 74.9 | 74.9 | 58.3 | 18.0 | 10.5 | 16.6 | 22.7 | 22.8 | 14.9 | 7.5 | 4.5 | 5.9 | 3.1 | 2.6 | 2.9 | 4.1 |
| Net Interest Expenses | — | — | — | (41.0) | (2.1) | 4.9 | 12.7 | 0.7 | 20.8 | 27.9 | 32.0 | 33.7 | 30.7 | 7.4 | 5.1 | 5.5 | 6.7 |
| Asset Writedown | — | 125.0 | — | 38.6 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 599.1 | 211.5 | — | — | — | — | — |
| EBT, Incl. Unusual Items | 149.1 | 482.5 | 541.8 | 188.6 | 149.6 | (75.4) | (42.3) | (94.8) | (142.7) | (35.9) | (831.1) | (154.7) | (124.9) | (176.5) | (118.3) | (43.6) | (21.5) |
| Income Tax Expense | 76.1 | 133.6 | 114.9 | 20.9 | 8.0 | (11.3) | (903.0) | (71.0) | (65.5) | 81.2 | (200.8) | 17.1 | 9.1 | (0.2) | (3.9) | 10.2 | (227.3) |
| Net Income | |||||||||||||||||
| Net Income | 73.0 | 348.9 | 426.9 | 167.6 | 141.6 | (64.1) | 854.0 | (23.8) | (77.2) | (117.0) | (630.2) | (171.8) | (134.0) | (176.4) | (114.3) | (53.8) | 205.8 |
| Per Share | |||||||||||||||||
| Basic EPS | 0.38 | 1.82 | 2.25 | 0.89 | 0.76 | (0.35) | 4.72 | (0.13) | (0.44) | (0.67) | (3.80) | — | — | — | (0.95) | (0.48) | 2.00 |
| Diluted EPS | 0.38 | 1.80 | 2.21 | 0.87 | 0.75 | (0.35) | 4.50 | (0.13) | (0.44) | (0.67) | (3.81) | — | — | — | (0.95) | (0.48) | 1.73 |
| Revenue per Share | 17.52 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 193.4 | 191.8 | 190.0 | 187.8 | 185.3 | 182.9 | 180.8 | 179.0 | 177.1 | 174.4 | 166.0 | — | — | — | 120.3 | 112.1 | 103.1 |
| Diluted Weighted Avg Shares | 194.5 | 197.4 | 196.7 | 191.6 | 189.0 | 182.9 | 191.7 | 179.0 | 177.3 | 174.4 | 166.2 | — | — | — | 120.3 | 112.1 | 125.7 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 489.0 | 580.6 | 290.2 | 262.9 | 25.7 | 61.7 | 4.8 | (27.9) | 73.2 | (706.5) | (63.5) | (36.1) | (108.7) | (65.9) | 1.2 | 28.3 |
| EBIT | 149.3 | 409.5 | 484.2 | 185.8 | 161.0 | (82.3) | (43.4) | (100.5) | (123.5) | (14.7) | (803.4) | (110.7) | (92.9) | (156.0) | (110.2) | (33.9) | 0.5 |
| Effective Tax Rate | 51.1% | — | — | 11.1% | 5.4% | 15.0% | 2133.7% | 74.8% | 45.9% | -226.2% | 24.2% | -11.0% | -7.3% | 0.1% | 3.3% | -23.4% | 1057.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.